Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 5945 record(s)

Req # A-2021-001661

Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: 000959405, 000959510, 967561, 967663, 967937, E2B_04503217, E2B_02542335, 969473, 969217, 969160, 969241, 969790, 969034, E2B_04555899, E2B_04587947, 968490, 968946, 968208, 968412, 970416.

Organization: Health Canada

394 page(s)
February 2024

Req # A-2021-001690

Adverse Drug Reaction (ADR) for LEFLUNOMIDE. Report number: 000968623.

Organization: Health Canada

14 page(s)
February 2024

Req # A-2021-001764

Adverse Drug Reactions (ADRs) for ALEMTUZUMAB, METRONIDAZOLE. Report numbers: 000950404, E2B_04594436.

Organization: Health Canada

21 page(s)
February 2024

Req # A-2022-000017

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-101219-184.

Organization: Health Canada

5 page(s)
February 2024

Req # A-2022-000179

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-101219-184.

Organization: Health Canada

5 page(s)
February 2024

Req # A-2022-000628

Adverse Drug Reactions (ADRs). Report numbers: E2B_00039133, E2B_00091820, E2B_02201561, E2B_02229967, E2B_02978450, E2B_02979471, E2B_02992182, E2B_03104617, E2B_02827797.

Organization: Health Canada

209 page(s)
February 2024

Req # A-2022-000751

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-108092-418.

Organization: Health Canada

48 page(s)
February 2024

Req # A-2022-000779

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-075262-896, Follow Up to 2019 National Indigenous Economic Development Board Progress Report Recommendations.

Organization: Health Canada

210 page(s)
February 2024

Req # A-2022-001539

Adverse Drug Reactions (ADRs). Report numbers: E2B_04042181, E2B_04048665, E2B_04073680, 000958710, 000962869, E2B_04099030, E2B_04186572, E2B_04198568, E2B_04208689, E2B_04238483.

Organization: Health Canada

293 page(s)
February 2024

Req # A-2023-000288

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-102433-804.

Organization: Health Canada

19 page(s)
February 2024
Date modified: